Free Trial

National Research Corporation (NASDAQ:NRC) Plans $0.12 Quarterly Dividend

National Research logo with Business Services background

Key Points

  • National Research Corporation announced a quarterly dividend of $0.12 per share, with shareholders on record to receive payments on October 10th, representing an annualized dividend of $0.48 and a yield of 3.62%.
  • The company's stock price decreased by 4.9%, closing at $13.26, with a market capitalization of $302.06 million and a P/E ratio of 12.87.
  • Recent institutional trading showed increased interest, with notable investments from organizations like Jane Street Group LLC, which raised its stake by 394.2%.
  • Looking to export and analyze National Research data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

National Research Corporation (NASDAQ:NRC - Get Free Report) declared a quarterly dividend on Tuesday, July 29th, Wall Street Journal reports. Investors of record on Friday, September 26th will be paid a dividend of 0.12 per share on Friday, October 10th. This represents a c) annualized dividend and a yield of 3.8%. The ex-dividend date is Friday, September 26th.

National Research Price Performance

NASDAQ NRC traded up $0.08 on Friday, hitting $12.58. The stock had a trading volume of 192,643 shares, compared to its average volume of 84,093. The firm has a 50-day moving average of $15.27 and a 200-day moving average of $14.64. The company has a debt-to-equity ratio of 1.98, a quick ratio of 0.54 and a current ratio of 0.54. National Research has a 52-week low of $9.76 and a 52-week high of $26.02. The company has a market capitalization of $286.57 million, a price-to-earnings ratio of 16.55 and a beta of 0.44.

National Research (NASDAQ:NRC - Get Free Report) last posted its quarterly earnings data on Monday, July 28th. The company reported $0.28 earnings per share for the quarter. National Research had a net margin of 12.78% and a return on equity of 76.61%. The company had revenue of $34.04 million for the quarter.

About National Research

(Get Free Report)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.

Featured Stories

Dividend History for National Research (NASDAQ:NRC)

Should You Invest $1,000 in National Research Right Now?

Before you consider National Research, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Research wasn't on the list.

While National Research currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Market’s Next Big Winners? Start Here
5 High Short Interest Stocks to Buy Before November
HUGE Upside Ahead: The Fastest Growing ETFs in the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines